Nearly 63% of patients also reported reduced or eliminated opioid usage after six months of using medical cannabis.
For the first time, a major scientific study has confirmed what cannabis advocates have known for decades: that cannabis can be a safe and effective palliative treatment in patients suffering from the debilitating effects of cancer.
Cannabinoids have demonstrated potential as treatments for liver diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and fibrosis.
In a unique and potentially transformative drug delivery technique, PreveCeutical Medical is engineering the world's first nose-to-brain drug delivery platform.
A new study suggests that smoking cannabis may lower the number of prescription opioids needed to produce pain relief.
The Cannabis Science, Dana-Farber research team has now begun next level planning to bring this efficacious research to full commercialization.
As cannabis has anti-inflammatory properties there may be potential for topical cannabis to improve conditions such as acne, psoriasis and eczema by reducing the inflammation associated with these diseases.